Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

Clinical trial NCT01966419 · COMPLETED

Trial details

NCT number: NCT01966419
Sponsor: Ocera Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Episode of Overt Hepatic Encephalopathy Hepatic Encephalopathy

Start date: 2014-01-07
Primary completion: 2016-12-29
Enrollment: 231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.